Acurx Pharmaceuticals Llc Stock In The News
| ACXP Stock | USD 0.46 0.01 2.13% |
Our overall analysis of Acurx Pharmaceuticals' news coverage and content from conventional and social sources shows investors' bearish mood towards Acurx Pharmaceuticals LLC. The specific impact of Acurx Pharmaceuticals news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Acurx Pharmaceuticals' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Acurx Pharmaceuticals headlines in addition to utilizing other, more conventional financial analysis modules. Check out Acurx Pharmaceuticals Backtesting and Acurx Pharmaceuticals Hype Analysis.
Acurx |
Acurx Pharmaceuticals Today Top News and Investor Outlook
Acurx Pharmaceuticals LLC Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Acurx and other traded companies coverage with news coverage. We help investors stay connected with Acurx headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Acurx Stock performance. Please note that trading solely based on the Acurx Pharmaceuticals LLC hype is not for everyone as timely availability and quick action are needed to avoid losses.
Acurx Pharmaceuticals stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Acurx earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Acurx Pharmaceuticals that are available to investors today. That information is available publicly through Acurx media outlets and privately through word of mouth or via Acurx internal channels. However, regardless of the origin, that massive amount of Acurx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Acurx Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Acurx Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Acurx Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Acurx Pharmaceuticals alpha.
Acurx Largest EPS Surprises
Earnings surprises can significantly impact Acurx Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-13 | 2024-09-30 | -0.2 | -0.17 | 0.03 | 15 | ||
2023-11-13 | 2023-09-30 | -0.27 | -0.24 | 0.03 | 11 | ||
2024-08-08 | 2024-06-30 | -0.22 | -0.26 | -0.04 | 18 | ||
2024-05-14 | 2024-03-31 | -0.24 | -0.28 | -0.04 | 16 | ||
2023-05-12 | 2023-03-31 | -0.29 | -0.25 | 0.04 | 13 | ||
2022-11-10 | 2022-09-30 | -0.28 | -0.32 | -0.04 | 14 |
Acurx Pharmaceuticals Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Acurx Pharmaceuticals LLC Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
11th of March 2025
Acquisition by Shawah Robert G. of 70000 shares of Acurx Pharmaceuticals at 6.26 subject t... at MacroaxisInsider
7th of March 2025
Acurx Pharmaceuticals, Inc. Announces 1.1 Million Registered Direct Offering at finance.yahoo.com
6th of March 2025
Acquisition by Donohue James J. of 9852 shares of Acurx Pharmaceuticals at 1.015 subject t... at MacroaxisInsider
3rd of March 2025
Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstats Gut ... at finance.yahoo.com
24th of February 2025
Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Mic... at finance.yahoo.com
5th of February 2025
Acquisition by Robert DeLuccia of 250000 shares of Acurx Pharmaceuticals at 0.7982 subject... at MacroaxisInsider
10th of January 2025
Joseph C. Scodari Acquires 24,631 Shares of Acurx Pharmaceuticals, Inc. Stock at thelincolnianonline.com
8th of January 2025
ACXP stock touches 52-week low at 0.72 amid market challenges - Investing.com at news.google.com
6th of January 2025
Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for ... at finance.yahoo.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Acurx Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Acurx Pharmaceuticals' short interest history, or implied volatility extrapolated from Acurx Pharmaceuticals options trading.
Additional Tools for Acurx Stock Analysis
When running Acurx Pharmaceuticals' price analysis, check to measure Acurx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acurx Pharmaceuticals is operating at the current time. Most of Acurx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acurx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acurx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acurx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.